Global Bipolar Disorder Therapeutic Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 – 2025
Bipolar disorder also known as manic depression refers to abnormal pattern of elevated mood and depression. Common signs of the condition include, maniac episodes, depressive episodes, hypomanic episodes, associated features, comorbid conditions and others. Exact cause of the condition is not known. However, three causes are observed to be closely associated with bipolar disorder which include, environmental conditions, genetic history or neurological abnormality.
Bipolar disorder is managed in three different ways namely, psychological treatment, medicines and alternative medications. Lithium, and ketamine are potential medications for the treatment of the condition. In addition, mood stabilizers such as carbamazepine, valproic acid and lamotrigine are used. Antipsychotics such as Olanzapine is sometimes used in the treatment. Antidepressants such as aripiprazole are also used during the course of treatment. AstraZeneca, AstraZeneca, JnJ Pharmaceticals, Novartis AG, Eli Lilly, Abbott and Otuska Holdngs Co. Ltd. Are some of the players operating in the market.
Rising prevalence of bipolar disorder is driving the growth of the market across the world. In addition, government support in creating awareness regarding the conditions and commercially available treatment options is supporting the market growth. Moreover, technological advancement in accurate detection of the condition at an early stage is supporting the market growth. On the other hand, social stigma associated with receiving treatment for mental disorders is challenging the market growth, mainly in developing countries of Asia Pacific and Latin America.
The major manufacturers covered in this report
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
Other regions (Central & South America, Middle East & Africa)
We can also provide the customized separate regional or country-level reports, for the following regions:
Rest of Asia-Pacific
Rest of Europe
Central & South America
Rest of South America
Middle East & Africa
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
By Application, the market can be split into
The study objectives of this report are:
To analyze and study the global Bipolar Disorder Therapeutic capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Bipolar Disorder Therapeutic manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Bipolar Disorder Therapeutic are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Bipolar Disorder Therapeutic Manufacturers
Bipolar Disorder Therapeutic Distributors/Traders/Wholesalers
Bipolar Disorder Therapeutic Subcomponent Manufacturers
With the given market data, ARC Offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Bipolar Disorder Therapeutic market, by end-use.
Detailed analysis and profiles of additional market players.